POU5F1 and ovarian cancer: For example, Oct4 expression is increased in docetaxel and mitoxantrone-resistant prostate cancer, cisplatin-resistant lung and ovarian cancer, radiation-resistant cervical cancer and chemo-resistant oral squamous carcinoma cancers (82, 86, 87).